glp-1 ras drugs Mapping the effectiveness and risks of receptor agonists Frontiers | GLP-1 RAs and
Description
Its benefits on CVD in the form of weight reduction 2-4 kg versus placebo and 4.8 kg versus insulin treated patients
K., Patorno, E
P.TcitoL
2025;26:e13841
Bone health is also a concern, especially for women in menopause who are already at risk for bone loss
With the surge in demand for GLP-1s, online weight-loss programs and telehealth retailers selling compounded versions of Ozempic or similar medications have exploded, seemingly overnight
